IADR Abstract Archives

TiF4 Varnish for Treatment of Caries in Children Permanent Dentition

Objectives: This 6-month randomized clinical trial (RTC) compared the effect of 4% TiF4 varnish with a commercial 5% NaF varnish in the treatment of noncavitated enamel carious lesions in permanent teeth of children living in a fluoridated area.
Methods: This randomized, controlled, parallel and single blind clinical trial involved 63 children, 6-7 years old, living in Bauru-SP/Brazil. Children were selected according to their caries activity (presence of at least 1 tooth with score Nyvad 1) and randomly divided into the following treatments: 4% TiF4 varnish (2.45% F-, pH 1, FGM); 5% NaF varnish (2.26% F-, pH 5, Duraphat®, Colgate) and negative control (placebo varnish, pH 5, FGM). The varnishes were applied on all permanent teeth, once a week for 4 consecutive weeks. Two calibrated examiners carried out the clinical examination (Nyvad index, kappa>0.8) at baseline, after the 1st and 6th month of the beginning of the study. Quantitative fluorescence changes were also measured using QLF device at the same periods. The degree of patient satisfaction with the treatment was also reported.
Results: Slight clinical and fluorescence changes were seen in the lesions during the period of the study. No significant differences between treatments with respect to caries lesions regression or progression (Nyvad-index) were detected after the 1st (Kruskal-Wallis/Wilcoxon, p>0.05) and the 6th month (Table 1). Also no differences between the treatments were detected with respect to the lesion area (WS) and the mean fluorescence loss (ΔF) (ANOVA/Kruskal-Wallis, p>0.05, Table 1). Regardless of the treatment, more than 75% of the participants reported to be satisfied with the treatments.
Conclusions: In conclusion, the fluoride treatments did not improve remineralization of noncavitated enamel carious lesions during 6 months of follow up. The participants will be still under follow up for a total period of 18 months, to check possible differences between the fluoride varnishes.
IADR/PER General Session
2018 IADR/PER General Session (London, England)
London, England
2018
0807
Cariology Research-Clinical & Epidemiological Studies
  • Souza, Beatriz  ( University of São Paulo , Bauru, SP , Brazil )
  • Dos Santos, Daiana  ( University of São Paulo , Bauru, SP , Brazil )
  • Braga, Aline  ( University of São Paulo , Bauru, SP , Brazil )
  • Dos Santos, Natália  ( University of São Paulo , Bauru, SP , Brazil )
  • Rios, Daniela  ( University of São Paulo , Bauru, SP , Brazil )
  • Buzalaf, Marilia Afonso Rabelo  ( University of São Paulo , Bauru, SP , Brazil )
  • Magalhães, Ana  ( University of São Paulo , Bauru, SP , Brazil )
  • FAPESP (2015/14149-1) and CNPq (401313/2016-6)
    NONE
    Poster Session
    Cariology Research: Clinical & Epidemiological Studies III
    Thursday, 07/26/2018 , 11:30AM - 12:45PM
    Table 1. Median (minimum to maximum values) of Nyvad index and the parameters obtained in the QLF analysis at 6th month of the study
     Nyvad indexArea WS (mm2)ΔF (%)
    TiF4NaFPlaceboTiF4NaFPlaceboTiF4NaFPlacebo
    Baseline1.0
    (0.5 to 1.0)
    1.0
    (0.3 to 1.0)
    1.0
    (0.5 to 1.0)
    2.4
    (1.4 to 4.8)
    3.1
    (0.1 to 5.6)
    2.6
    (1.7 to 7.2)
    -16.0
    (-27 to -10)
    -15.3
    (-22 to -8)
    -15.0
    (-21 to -13)
    6 months1.0
    (1.0 to 2.3)
    1.0
    (1.0 to 1.7)
    1.0
    (1.0 to 1.0)
    2.9
    (1.6 to 5.7)
    3.1
    (1.9 to 6.5)
    2.5
    (1.4 to 4.8)
    -15.3
    (-21 to -12)
    -16.9
    (-20 to -10)
    -13.9
    (-17 to -12)
    For Nyvad Index: Kruskal-Wallis for comparison between the treatments (p>0.05). Mann-Whitney for the comparison between the periods for each treatment (p>0.05). For QLF parameters: ANOVA for comparison between the treatments (p>0.05). Wilcoxon for the comparison between the periods for each treatment (p>0.05). TiF4 (n=11) NaF (n=12) and Placebo (n=11). * Reduction of the values between the periods shows regression of the carious lesions.